Search Results
Testing for BRCA Germline Mutations in the Clinic and the Mechanism of Action of PARP Inhibitors
The Role of Targeting DNA Repair with PARP
Role of PARP Inhibitors in Prostate Cancer
PARP Inhibitors in 2020: Where Are We Now, and Where Are We Going | Webinar | Ambry Genetics
Detecting Somatic BRCA1/2 Mutations in Ovarian Cancer
ACTG Dinner Symposium Highlights | Beyond BRCA testing – does HRD matter? | Prof Michael Friedlander
Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy
Ovarian Cancer: Testing for BRCA Mutations
PARP Inhibitors
PARP inhibitors – a cancer drug discovery story | Professor Ruth Plummer FMedSci
Optimizing BRCA Testing in Advanced Ovarian Cancer
PARP Inhibitors in Ovarian Cancer Treatment | Webinar | Ambry Genetics
